1. Using a novel NQO1 bioactivatable drug, beta‐lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer. Issue 1 (27th March 2017) Authors: Beg, Muhammad Shaalan; Huang, Xiumei; Silvers, Molly A.; Gerber, David E.; Bolluyt, Joyce; Sarode, Venetia; Fattah, Farjana; Deberardinis, Ralph J.; Merritt, Matthew E.; Xie, Xian‐Jin; Leff, Richard; Laheru, Daniel; Boothman, David A. Other Names: Melstrom Laleh G. guestEditor.; Singh Gagandeep guestEditor.; Fong Yuman guestEditor. Journal: Journal of surgical oncology Issue: Volume 116:Issue 1(2017) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗